Raptor Pharmaceutical Corp. (RPTPD) Appoints Seasoned Member to Board of Directors
Raptor Pharmaceutical Corp., a company focused on accelerating the speed of new treatment to patients by improving existing therapeutics, yesterday announced the appointment of Llew Keltner, M.D., Ph.D., to the company’s board of directors. Dr. Keltner currently serves as CEO and president of Light Sciences Oncology, a privately held biotechnology company focused on late-stage, light-activated therapy for hepatocellular cancer and solid tumors. Dr. Keltner is also the CEO of EPISTAT, an international healthcare technology transfer, corporate risk management and healthcare strategy company he founded in 1972. Christopher M. Starr, Ph.D., CEO of Raptor, said Dr. Keltner’s more than 30 years…